Heterotropic cooperativity in oxidation mediated by cytochrome p450

Area of Science:

• Biochemistry
• Pharmacology
• Enzymology

Background:

• Cytochrome P450 enzymes (CYPs) are crucial for metabolizing xenobiotics.
• Most P450 inhibitors decrease enzyme activity, but some compounds cause activation (heterotropic cooperativity).
• Understanding CYP-xenobiotic interactions is vital for drug development and toxicology.

Purpose of the Study:

• To review kinetic data (Km, Vmax, intrinsic clearance) for CYP activators and substrates.
• To explore the phenomenon of P450 activation, particularly for CYP3A4 and other human CYP isoforms.
• To discuss proposed mechanisms and highlight knowledge gaps in P450 cooperativity.

Main Methods:

• Literature review and summarization of published kinetic data for CYP activators and substrates.
• Analysis of reported metabolic activities and cooperativity phenomena across different CYP forms.
• Compilation of data for 22 activators and 24 substrates involving 30 reactions, primarily mediated by CYP3A4.

Main Results:

• Data for 22 activators and 24 substrates (30 reactions) primarily involving human CYP3A4 were summarized.
• Activation patterns are substrate- and enzyme source-dependent, suggesting complex interactions.
• CYP1A2, CYP2C8, CYP2C9, CYP2D6, and CYP3A7 show activation, while CYP3A5 has fewer reports.
• Contradictory kinetic parameters for identical reactions were noted across studies.

Conclusions:

• P450 activation by chemicals is a complex phenomenon, with mechanisms not fully elucidated.
• While allosteric models exist, substrate and enzyme specificities complicate understanding.
• Further research is needed to clarify the causal factors and mechanisms underlying P450 cooperativity and its clinical relevance.